The Efficacy of Vedolizumab, an alpha4beta7 Integrin Antibody, in Crohn's Disease and Ulcerative Colitis.

Author: Eun Sun KIM ¹
Author Information

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Digestive Disease and Nutrition, Korea University College of Medicine, Seoul, Korea. silverkes@naver.com
Publication Type:Note
MeSH: Antibodies, Monoclonal, Humanized; Colitis, Ulcerative*; Crohn Disease*; Ulcer*
From:Intestinal Research 2013;11(4):325-326
CountryRepublic of Korea
Language:Korean
Abstract: No abstract available.